TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotage AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 1,481,299 | 1,201,474 | 1,144,272 |
Financial expenses | 13,243 | 11,703 | 8,811 |
Earnings before taxes | 329,178 | 262,335 | 233,331 |
EBITDA | 405,797 | 338,402 | 293,152 |
Total assets | 2,212,490 | 1,942,643 | 1,502,723 |
Current assets | 975,236 | 754,822 | 787,393 |
Current liabilities | 391,608 | 302,319 | 227,710 |
Equity capital | 1,548,459 | 1,337,030 | 1,037,165 |
- share capital | 87,970 | 89,720 | 95,299 |
Employees (average) | 517 | 497 | 463 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 70.0% | 68.8% | 69.0% |
Turnover per employee | 2,865 | 2,417 | 2,471 |
Profit as a percentage of turnover | 22.2% | 21.8% | 20.4% |
Return on assets (ROA) | 15.5% | 14.1% | 16.1% |
Current ratio | 249.0% | 249.7% | 345.8% |
Return on equity (ROE) | 21.3% | 19.6% | 22.5% |
Change turnover | 315,935 | 136,260 | -9,528 |
Change turnover % | 27% | 13% | -1% |
Chg. No. of employees | 20 | 34 | 23 |
Chg. No. of employees % | 4% | 7% | 5% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.